Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Eden vs Oxford's Medical Weight Loss (The Calibrate Clinic)

Two GLP-1 desks, one scoreboard. We put Eden and Oxford's Medical Weight Loss (The Calibrate Clinic) head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 3 · Grade A−

Eden

Visit Eden Full brief →
vs
No. 343 · Grade C

Oxford's Medical Weight Loss (The Calibrate Clinic)

Visit Oxford's Medical Weight Loss (The Calibrate Clinic) Full brief →

The verdict

Eden takes this head-to-head.

Eden scores 91 to 59 on our six-factor Brief Score — A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

That doesn't make Oxford's Medical Weight Loss (The Calibrate Clinic) a bad call — it's best for readers who want mainstream telehealth glp-1 access. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
89
40
Supply Reliability
92
73
Transparency
93
63
Access Breadth
90
36
Clinical Oversight
92
76
Track Record
89
74
EdenBrief Score 91 · 59Oxford's Medical Weight Loss (The Calibrate Clinic)

Price, coverage & the tracker

EdenOxford's Medical Weight Loss (The Calibrate Clinic)
Brief Score91/100 (A−)59/100 (C)
Semaglutide$239/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 states2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Eden: Premium line steady; high supply-chain disclosure keeps our confidence high.

Oxford's Medical Weight Loss (The Calibrate Clinic): New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.